Skip to content

A experimental study of karnavedhana procedure in Tamaka shwasa with souvarchaladi churna

Clinical Study on the effect of Souvarchaladi Churna and Karnavedhana on Tamaka shwasa with special reference to Bronchial Asthma.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054480
Enrollment
60
Registered
2023-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J709- Respiratory conditions due to unspecified external agent Health Condition 2: J455- Severe persistent asthma

Interventions

None listed

Sponsors

Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate in the study. 2. Patients of either sex with age between 18-60 years. 3. Patients with history of Tamaka Shwasa less than 5 years. 4. Patients presenting with classical features of Tamak Shwasa. 5. Peak flow meter rate more than 80 lit/min and less than 300 lit/min 6. FVC (Forced Vital Capacity) and FEV1 (Forced Expiratory volume in one second) more than 60% and less than 80%. 7. FEV1/FVC ratio more than 5% and less than 20%

Exclusion criteria

Exclusion criteria: 1. Patients not willing to participate in the study. 2. Patients of either sex below 18 years & above 60 years will be excluded from the study. 3. Patient with history of Tamak Shwasa more than 5 years. 4. Pregnant and lactacting women. 5. Emphysema 6. Bronchial Carcinoma 7. Pleural Effusion. 8. Tuberculosis. 9. Neurological disorders like epilepsy, heamorrhagic stroke, meningitis. 10. Psychological disorders 11. Status Asthmaticus 12. Diabetes mellitus 13. Hypertensive patient 14. Occupational asthma, Cardiac Asthma. 15. Emergency patients requiring O2 inhalation.

Design outcomes

Primary

MeasureTime frame
Relief in Breathlessness at rest, duration of attack, ,cough, expectoration, wheezing, running nose, Chest painTimepoint: 15 days

Secondary

MeasureTime frame
Relief in Breathing difficulty, expulsion of sputum ,running noseTimepoint: 2 month

Countries

India

Contacts

Public ContactProf Rajendra Prasad

Banaras Hindu University

rajendraprasad051@gmail.com9411471910

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026